Skip to main content
SpringerLink
Log in

GH/IGF-I axis in Prader-Willi syndrome: Evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Basal IGF-I levels and the GH response to at least two among provocative stimuli such as clonidine (CLO, Catapresan, 150 mcg/m2 po), GHRH (1 mcg/kg iv)+arginine (ARG, 0.5 g/kg iv infusion during 30 min) and GHRH+pyridostigmine (PD, Mestinon cpr 60 mg po) have been evaluated in 43 children with Prader-Willi syndrome (PWS, 17 males and 26 females, age 3–22 yr, 7 normal weight and 36 obese PWS), in 25 normal short children (NC, 17 males and 8 females, 7.7–18.5 yr) and in 24 children with simple obesity (OB, 14 males, 10 females, 7.7–21.5 yr). Both normal weight and obese PWS had mean IGF-I levels lower than those recorded in NC (p<0.001) and OB (p<0.001). The GH responses to GHRH+ARG and GHRH+PD in NC were similar and higher than that to CLO (p<0.001). In PWS the GH response to GHRH+ARG was higher than that to GHRH+PD (p<0.001) which, in turn, was higher than that to CLO (p<0.001); these responses in PWS were lower than those in normal children (p<0.02) and similar to those in OB. In normal weight PWS the GH responses to GHRH+ARG and to GHRH+PD were similar and higher than to CLO (p<0.05); however, each provocative stimulus elicited a GH rise lower than that in NC (p<0.05). In obese PWS as well as in OB the GH response to GHRH+ARG was higher than that to GHRH+PD (p<0.02) which, in turn, was higher than that to CLO (p<0.001); all GH responses in obese PWS and OB were lower than those in NC (p<0.001) but similar to those in normal weight PWS. In conclusion, patients with PWS show clear reduction of IGF-I levels as well as of the somatotroph responsiveness to provocative stimuli independently of body weight excess. These results strengthen the hypothesis that PWS syndrome is frequently connoted by GH insufficiency.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ledbetter D., Riccardi V., Airhart S., Strobel R., Keenen S., Crawford J. Deletion of cromosome 15 as a cause of the Prader Willi Syndrome. N. Engl. J. Med. 1981, 11: 304–325.

    Google Scholar 

  2. Carrozzo R., Rossi E., Christian S., Kittickamron K., Livieri C., Corrias A., Pucci L., Fois A., Simi P., Bosio L., Beccaria L., Zuffardi O., Ledbetter D. Inter and intrachromosomal rearrangements qre bth involved in the origin of 15 q11–q13 deletion. Am. J. Hum. Genet. 1997, 61: 228–232.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Nicholls R., Knoll J., Butker M., Karam S., Lalande M. Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader Willi syndrome. Nature (London) 1989, 342: 281–285.

    Article  CAS  Google Scholar 

  4. Holm V.C., Cassidy S.B., Butler M.G., Hanchett J.M., Greenswag L.R., Witman B.Y., Greemberg F. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 1993, 91: 398–402.

    CAS  PubMed  Google Scholar 

  5. Donaldson M., Chu C., Cooke A., Wilson A., Greene S., Stephenson J. The Prader Willi syndrome. Arch. Dis. Child. 1994, 70: 58–63.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Hanson J. A view of etiology and pathogenesis of Prader — Willi syndrome. In: Holm V.A., Sulzbacher S.J., Pipe P.L. (Eds.), The Prader-Willi syndrome. University Park Press, Baltimore, 1981, p. 45.

    Google Scholar 

  7. Swaab D., Purba J. S., Hofman M.A. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. J. Clin. Endocrinol. Metab. 1995, 80: 573–579.

    CAS  PubMed  Google Scholar 

  8. Costeff H., Holm V.A., Ruvalcaba R., Shaver J. Growth hormone secretion in Prader-Willi syndrome. Acta Paediatr. Scand. 1990, 79: 1059–1062.

    Article  CAS  PubMed  Google Scholar 

  9. Cappa M., Grossi A., Borrelli P., Ghigo E., Bellone J., Benedetti S., Carta D., Loche S. Growth homone (GH) response to combined Pyridostigmine and GH-releasing hormone administration in patients with Prader — Labhard — Willi Syndrome. Horm. Res. 1993, 39: 51–55.

    Article  CAS  PubMed  Google Scholar 

  10. Angulo M., Castro-Magana M., Mazur B., Canas J., Vitollo P., Sarrantonio M. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader Willi Syndrome. J. Paed. Endocrinol. Metab. 1996, 9: 393–400.

    Article  CAS  Google Scholar 

  11. Beccaria L., Bosio L., Sanzari A., Aimaretti G., Ghigo E., Chiumello G. GH secretion in Prader-Labhard — Willi Syndrome: somatotrope responsiveness to GHRH is enhanced by arginine but not by pyridostigmine. J. Paed. Endocrinol. Metab. 1996, 9: 577–583.

    Article  CAS  Google Scholar 

  12. Grugni G., Guzzaloni G., Moro D., Bettio D., De Medici C., Morabito F. Reduced growth hormone (GH) responsiveness to combined GH-releasing hormone and pyridostigmine administration in the Prader Willi syndrome. Clin. Endocrinol. 1998, 48: 769–775.

    Article  CAS  Google Scholar 

  13. Ranke M.B., Haber P. Growth hormone stimulation tests. In: Ranke M.B. (Eds.), Functional endocrinologic diagnostic in children and adolescents. I.&J., Verlag Mannheim, 1992, p. 61.

    Google Scholar 

  14. Ghigo E., Bellone J., Aimaretti G., Bellone S., Loche S., Cappa M., Bartolotta E., Dammacco F., Camanni F. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J. Clin. Endocrinol. Metab. 1996, 81: 3323–3327.

    CAS  PubMed  Google Scholar 

  15. Cole T.J. A method for assessing age standardised weight for height in children seen cross sectionally. Ann. Hum. Biol. 1979, 7: 457–473.

    Google Scholar 

  16. Iranmanesh A., Lizarralde G., Veldhuis J.D. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory burts and the half-life of endogenous GH in healthy man. J. Clin. Endocrinol. Metab. 1991, 73: 1081–1088.

    Article  CAS  PubMed  Google Scholar 

  17. Veldhuis J.D., Iranmanesh A., Ho K.K.Y., Waters M.J., Johmson M.L., Lizarralde G. Dual defect in pulsatile growth hormone secretion and clearance subserve the hyposomatotropinism of obesity in man. J. Clin. Endocrinol. Metab. 1991, 72: 51–59.

    Article  CAS  PubMed  Google Scholar 

  18. Topper E., Gil-Ad I., Bauman B., Josefaberg Z., Laron Z. Plasma growth hormone response to oral clonidine as compared to insulin hypoglicemia in obese children and adolescents. Horm. Metab. Res. 1984, 1: 127–130.

    Google Scholar 

  19. Loche S., Balzano S., Bozzola M., Moretta A., Pintus S., Faedda A., Muntoni A., Carta D., Pintor C. Secretion of growth hormone releasing hormone in obese children. J. Endocrinol. Invest. 1992, 15: 453–457.

    CAS  PubMed  Google Scholar 

  20. Cordido F., Casanueva F.F., Dieguez C. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects. J. Clin. Endocrinol. Metab. 1989, 68: 290–293.

    Article  CAS  PubMed  Google Scholar 

  21. Rasmussen M.H., Hvidberg A., Juul A., Main K.M., Gotfredsen A., Skakkebaek M., Hilsted J. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I in obese subjects. J. Endocrinol. Metab. 1995, 80: 1407–1415.

    CAS  Google Scholar 

  22. Tannenbaum G.S., Lapointe M., Gurd W., Finkelstein J.A. Mechanism of impaired growth hormone secretion in genetically obese zucher rats: roles of growth hormone-releasing factor and somatostatin. Endocrinology 1990, 127: 3087–3091.

    Article  CAS  PubMed  Google Scholar 

  23. Ghigo E., Mazza E., Corrias A., Imperiale E., Goffi S., Arvat E., Bellone J., de Sanctis C., Muller E.E., Camanni F. Effect of cholinergic enhancement by pyridostigmine on growth hormone secretion in obese adults and children. Metabolism 1989, 38: 631–633.

    Article  CAS  PubMed  Google Scholar 

  24. Ghigo E., Procopio M., Maccario M., Bellone J., Arvat E., Campana S., Boghen M.F., Camanni F. Repetitive GHRH administration fails to increase to GHRH in obese subjects. Evidence for a somatotrope defect in obesity? Horm. Metab. Res. 1993, 25: 305–308.

    Article  CAS  PubMed  Google Scholar 

  25. Maccario M., Procopio M., Grottoli S., Oleandri S.E., Boffano G.M., Taliano, M., Camanni F., Ghigo E. Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity. Metabolism 1996, 45: 1–6.

    Article  Google Scholar 

  26. Cordido F., Peino R., Penalva A., Alvarez C.V., Casanueva F.F., Dieguez C. Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression. J. Clin. Endocrinol. Metab. 1996, 81: 914–918.

    CAS  PubMed  Google Scholar 

  27. Frystyk J., Skjaerbaek E., Mogensen C.E., Orskov H. Free insulin-like growth factor in human obesity. Metabolism 1995, 44 (Suppl. 4): 37–44.

    Article  CAS  PubMed  Google Scholar 

  28. Loche S., Cappa M., Borrelli P., Faedda A., Crinò A., Cella S.G., Corda R., Muller E.E., Pintor C. Reduced growth hormone response to growth hormone-releasing hormone in children with simple obesity: evidence for a somatomedin-C mediated inhibition. Clin. Endocrinol. (Oxf.) 1987, 27: 145–150.

    Article  CAS  Google Scholar 

  29. Rudman D., Kutner M.H., Rogers C.M., Lubin M.F., Fleming G.A., Bain R.P. Impaired growth hormone secretion in adult population: relation to age and adiposity. J. Clin. Invest. 1981, 67: 1361–1369.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Ghigo E., Bellone J., Mazza E., Imperiale E., Procopio M., Valente F., Lala R., de Sanctis C., Camanni F. Arginine potentiates the GHRH- but not the pyridostigmine- induced GH secretion in normal short children. Further evidence for a somatostatin suppressing effect of arginine. Clin. Endocrinol. (Oxf.) 1990, 32: 763–767.

    Article  CAS  Google Scholar 

  31. Ghigo E., Arvat E., Goffi S., Nicolosi M., Arvat E., Procopio M., Bellone J., Valente F., Ghigo M.C., Camanni F. Repetitive GHRH and arginine administration to explore the maximal secretory capacity of somatotrope cells during lifespan. Clin. Exp. Endocrinol. 1991, 10: 191–198.

    Google Scholar 

  32. Blum W.F., Albertson-Wiekland K., Rosberg S., Ranke M.B. Serum levels of insulin-like growth factor (IGF-I) and IGF-I binding protein 3 spontaneous growth hormone secretion. J. Clin. Endocrinol. Metab. 1993, 76: 1610–1616.

    CAS  PubMed  Google Scholar 

  33. Grosso S., Cioni M., Buoni S., Peruzzi L., Pucci L., Berardi P. Growth hormone secretion in Prader-Willi syndrome. J. Endocrinol. Invest. 1998, 21: 418–422.

    CAS  PubMed  Google Scholar 

  34. Valetto M.R., Bellone J., Baffoni C., Savio P., Aimaretti G., Gianotti L., Arvat E., Camanni F., Ghigo E. Reproducibility of the growth hormone response to stimulation with growth hormone-releasing plus arginine during lifespan. Eur. J. Endocrinol. 1996, 135: 568–572.

    Article  CAS  PubMed  Google Scholar 

  35. Cappa M., Loche S., Salvadori R., Faedda A., Borrelli P., Cella S.G., Pintor C., Muller E.E. The GH response to pyridostigmine plus GHRH is not influenced by pubertal maturation. J. Endocrinol. Invest. 1991, 14: 41–45.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Endocrinology, Regina Margherita Hospital, Turin, Italy

    A. Corrias M.D., J. Bellone & M. Andreo

  2. Department of Pediatrics, Endocrine Unit, Scientific Institute, San Raffaele Hospital, University of Milan, Milan, Italy

    L. Beccaria & L. Bosio

  3. Department of Pediatrics, Sacco Hospital, Milan, Italy

    G. Trifirò

  4. Department of Pediatrics, University of Pavia, Italy

    C. Livieri

  5. Department of Pediatrics, OASI Institute, Troina, Enna, Italy

    L. Ragusa

  6. Department of Pediatrics, Circolo Hospital, Varese, Italy

    A. Salvatoni

  7. Department of Pediatrics, Burlo Garofalo Hospital, Trieste, Italy

    G. Tonini

  8. Division of Endocrinology, Bambino Gesù Hospital, Rome, Italy

    P. Ciampalini & A. Crinò

Authors
  1. A. Corrias M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Bellone
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Beccaria
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Bosio
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Trifirò
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. Livieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. L. Ragusa
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A. Salvatoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M. Andreo
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. P. Ciampalini
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. G. Tonini
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. A. Crinò
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabetology

Rights and permissions

Reprints and permissions

About this article

Cite this article

Corrias, A., Bellone, J., Beccaria, L. et al. GH/IGF-I axis in Prader-Willi syndrome: Evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. J Endocrinol Invest 23, 84–89 (2000). https://doi.org/10.1007/BF03343684

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343684

Key-words

Search

Navigation